证券时报e公司讯,太龙药业(600222)3月27日晚发布年报,2019年度,公司实现营收13.12亿元,同比增长9.79%;净利为4571万元,同比扭亏,上年同期亏损1.15亿元。
“特别声明:以上作品内容(包括在内的视频、图片或音频)为凤凰网旗下自媒体平台“大风号”用户上传并发布,本平台仅提供信息存储空间服务。
Notice: The content above (including the videos, pictures and audios if any) is uploaded and posted by the user of Dafeng Hao, which is a social media platform and merely provides information storage space services.”